Fanny Cavalié, MBA

Venture Partner

Fanny Cavalié is a Venture Partner at Raven. Fanny’s primary responsibility is to focus on new company creation. Fanny brings nearly twenty years of leadership experience in the life sciences industry, from drug discovery to commercial stages. Prior to Raven, Fanny served as Chief Strategy and Business Operations Officer at Foghorn Therapeutics from 2018 to 2024. During her tenure, Fanny built and led business functions, including corporate strategy, business development, alliance management, program leadership, commercial, corporate affairs and operations, in support of Foghorn’s IPO and growth into a clinical-stage company. Fanny also led the negotiation and operationalization of two key partnerships with Merck and Loxo@Lilly. Previously, Fanny spent four years at Biogen in various strategy and commercial positions, including Global Marketing lead for Alzheimer’s Disease and Global Strategy Lead for the Multiple Sclerosis portfolio. Fanny also spent a decade at McKinsey in Europe, advising a diverse portfolio of BioPharma’s, payers, and providers. As Associate Partner and Co-leader of the EMEA Pharma Launch service line, Fanny directed more than 50 projects encompassing strategy, organizational transformation, and product commercialization. Fanny holds a MBA from HEC Paris.